Correlation Between GlaxoSmithKline PLC and PEAK Old
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and PEAK Old at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and PEAK Old into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and PEAK Old, you can compare the effects of market volatilities on GlaxoSmithKline PLC and PEAK Old and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of PEAK Old. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and PEAK Old.
Diversification Opportunities for GlaxoSmithKline PLC and PEAK Old
-0.02 | Correlation Coefficient |
Good diversification
The 3 months correlation between GlaxoSmithKline and PEAK is -0.02. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and PEAK Old in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PEAK Old and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with PEAK Old. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PEAK Old has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and PEAK Old go up and down completely randomly.
Pair Corralation between GlaxoSmithKline PLC and PEAK Old
Considering the 90-day investment horizon GlaxoSmithKline PLC ADR is expected to generate 0.79 times more return on investment than PEAK Old. However, GlaxoSmithKline PLC ADR is 1.26 times less risky than PEAK Old. It trades about 0.01 of its potential returns per unit of risk. PEAK Old is currently generating about -0.04 per unit of risk. If you would invest 3,410 in GlaxoSmithKline PLC ADR on August 28, 2024 and sell it today you would earn a total of 5.00 from holding GlaxoSmithKline PLC ADR or generate 0.15% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 31.72% |
| Values | Daily Returns |
GlaxoSmithKline PLC ADR vs. PEAK Old
Performance |
| Timeline |
| GlaxoSmithKline PLC ADR |
| PEAK Old |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
GlaxoSmithKline PLC and PEAK Old Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with GlaxoSmithKline PLC and PEAK Old
The main advantage of trading using opposite GlaxoSmithKline PLC and PEAK Old positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, PEAK Old can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PEAK Old will offset losses from the drop in PEAK Old's long position.| GlaxoSmithKline PLC vs. Novartis AG ADR | GlaxoSmithKline PLC vs. AstraZeneca PLC ADR | GlaxoSmithKline PLC vs. Roche Holding Ltd | GlaxoSmithKline PLC vs. Bristol Myers Squibb |
| PEAK Old vs. Welltower | PEAK Old vs. Mid America Apartment Communities | PEAK Old vs. Regency Centers | PEAK Old vs. UDR Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| CEOs Directory Screen CEOs from public companies around the world |